​

Funding Round

Series C - Synthego

Series C - Synthego

Investment Firm

Overview

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Announced Date

Oct 23, 2018

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Founders Fund

Founders Fund

Founders Fund is a debt and early_stage_venture and grant and late_stage_venture and private_equity and seed firm.

Participant Investors

5

Investor Name
Participant InvestorZachary Hargreaves
Participant InvestorCyriac Roeding
Participant Investor8VC
Participant InvestorMenlo Ventures
Participant InvestorFounders Fund

Round Details and Background

Synthego raised $110000000 on 2018-10-23 in Series C

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 01, 2012
Seed Round - Synthego
1-undefined
Jan 04, 2017
Series B - Synthego
13-41.0M
Aug 14, 2012
Debt Financing - Synthego
-250.0K
Jul 05, 2013
Series A - Synthego
3-8.3M

Recent Activity

There is no recent news or activity for this profile.